Boston Scientific Corporation (BSX-PA) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Marlborough, MA, United States. The current CEO is Michael F. Mahoney.
BSX-PA has IPO date of 2020-05-22, 45,000 full-time employees, listed on the NYSE, a market capitalization of $175.45B.
Boston Scientific Corporation is a global medical device manufacturer that develops, manufactures, and markets innovative interventional medical technologies across three primary segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company's product portfolio spans diagnostic and therapeutic devices for gastrointestinal, pulmonary, urological, and cardiac conditions, as well as implantable systems such as pacemakers, defibrillators, and spinal cord stimulators for chronic pain management. Its cardiovascular offerings include drug-eluting stents, ablation catheters, coronary intervention products, and structural heart therapies, while its oncology solutions comprise embolization devices, ablation systems, and targeted delivery catheters. Headquartered in Marlborough, Massachusetts, and incorporated in 1979, Boston Scientific serves healthcare markets worldwide with a comprehensive range of medical technologies designed to improve patient outcomes across multiple therapeutic areas.
